$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer743,67511,192,309shares bought: 526,354 / shares sold: -614,257 SELLNov 17 20177 days ago
Clark Mitchall G.EVP & Chief R & QA Officer166,3422,503,447shares bought: 99,981 / shares sold: -20,391 STRONG BUYNov 17 20177 days ago
Fust Matthew KDirector30,503459,070shares bought: 16,615 / shares sold: 0 STRONG BUYNov 17 20177 days ago
Gallagher Carol GiltnerDirector110,1051,657,080shares bought: 23,561 / shares sold: -8,103 STRONG BUYNov 17 20177 days ago
Haqq ChristopherEVP, R&D & Chief Scientific Of344,1345,179,217shares bought: 145,304 / shares sold: -98,014 BUYNov 17 20177 days ago
MCGRATH JOHNEVP & Chief Financial Officer128,6541,936,243shares bought: 115,535 / shares sold: -70,595 BUYNov 17 20177 days ago
Sofer GadEVP & Chief Strategy Officer263,2363,961,702shares bought: 198,336 / shares sold: -68,492 STRONG BUYNov 17 20177 days ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 17 2017ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...Option ExerciseM0.004,14602,764
Nov 17 2017ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...SellS15.007,000105,000256,236263.2 K to 256.2 K (-2.66 %)
Nov 17 2017ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...BuyM0.004,1460263,236259.1 K to 263.2 K (+1.60 %)
Nov 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...Option ExerciseM0.008290553
Nov 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS13.361,60421,429342,530344.1 K to 342.5 K (-0.47 %)
Nov 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...BuyM0.008290344,134343.3 K to 344.1 K (+0.24 %)
Nov 17 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...Option ExerciseM0.005,90803,938
Nov 17 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...BuyM0.005,9080743,675737.8 K to 743.7 K (+0.80 %)
Nov 17 2017ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...Option ExerciseM0.007,212012,019
Nov 17 2017ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...SellS14.203,29046,718163,052166.3 K to 163.1 K (-1.98 %)
Nov 17 2017ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...BuyM0.007,2120166,342159.1 K to 166.3 K (+4.53 %)
Nov 17 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorOption ExerciseM0.001,60202,137
Nov 17 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorBuyM0.001,602030,50328.9 K to 30.5 K (+5.54 %)
Nov 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...Option ExerciseM0.007,69705,132
Nov 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...BuyM0.007,6970128,654121 K to 128.7 K (+6.36 %)

View all Atara Biotherapeutics, Inc. insider transactions.